Gastric Neuroendocrine Tumor Treatment Options

Gastric neuroendocrine tumors, often referred to as carcinoids, can be effectively managed depending on their size and stage. Smaller gastric carcinoids are typically treated using minimally invasive techniques such as endoscopic resection. These tumors are often detected early and can be completely removed during a routine endoscopic procedure.

For larger neuroendocrine tumors, surgical intervention may be necessary, similar to the approach used in gastric cancer treatment. After surgical removal, further treatment with chemotherapy or radiation therapy may be considered based on the pathological findings. However, in most cases, gastric neuroendocrine tumors are discovered at an early stage—often classified as Grade 1 (G1)—and can be fully removed without the need for additional therapy.

Endoscopic treatment is particularly effective for small, localized tumors measuring less than 1 cm and classified as G1. This approach offers a faster recovery time and fewer complications compared to traditional surgery. On the other hand, if the tumor is larger or classified as Grade 2 (G2), surgical resection is generally recommended to ensure complete removal and reduce the risk of recurrence.

In summary, there are two primary treatment strategies for gastric neuroendocrine tumors: endoscopic removal for early-stage, small tumors and surgery for more advanced or higher-grade lesions. The choice of treatment depends on tumor size, grade, and overall patient condition, ensuring the most effective and personalized care.